Loading financial statements…
Import this data to Google Sheets with:
=jivedata("CSAI","financials")Full statements spill as a table. For one cell: =jivedata("CSAI","Revenue") or =jivedata("CSAI","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.
CSAI • CIK 0001709628
| (in thousands, except per share data) | FY 2024 | FY 2025 | TTM |
|---|---|---|---|
| Revenues | $1,364 | $5,066 | $5,786 |
| Cost of Revenue | $990 | $3,577 | $3,711 |
| Gross Profit | $374 | $1,489 | $2,075 |
| General and Administrative Expense | $1,241 | $2,439 | $3,312 |
| Research and Development Expense | $1,266 | $1,883 | $2,173 |
| Selling and Marketing Expense | $1,813 | $2,882 | $3,198 |
| Other Noncash Expense | $2,174 | $2,432 | $2,432 |
| Operating Expenses | $6,493 | $9,635 | $10,569 |
| Operating Income (Loss) | $-6,119 | $-8,147 | $-8,496 |
| Interest Income, Other | $88 | $203 | $216 |
| Dividends, Preferred Stock | — | $513 | $564 |
| Litigation Settlement, Expense | $426 | $0 | $0 |
| Realized Investment Gains (Losses) | — | $-2 | $-2 |
| Net Income (Loss) Attributable to Parent | $-6,535 | $-8,462 | $-8,403 |
| Preferred Stock Dividends, Income Statement Impact | — | $1,963 | $1,272 |
| Net Income (Loss) Available to Common Stockholders, Basic | — | $-10,425 | $-10,038 |
| Weighted Average Number of Shares Outstanding, Basic | 14,591,554 | 18,829,585 | 2,035,996 |
| (in thousands, except per share data) | FY 2024 | FY 2025 | TTM |
|---|---|---|---|
| Cash and Cash Equivalents, at Carrying Value | $52 | $8,453 | $3,807 |
| Accounts Receivable, after Allowance for Credit Loss, Current | $196 | $874 | $1,014 |
| Inventory, Net | $249 | $304 | $282 |
| Other Assets, Current | $38 | $186 | $558 |
| Assets, Current | $535 | $9,817 | $5,661 |
| Property, Plant and Equipment, Net | $80 | $305 | $298 |
| Assets | $615 | $10,122 | $5,959 |
| Accounts Payable, Current | $629 | $531 | $237 |
| Accrued Liabilities, Current | $0 | $8 | $97 |
| Deferred Revenue, Current | $489 | $590 | $590 |
| Dividends Payable, Current | — | $83 | $134 |
| Liabilities, Current | $1,118 | $1,212 | $1,142 |
| Preferred Stock, Value, Issued | — | $0 | $0 |
| Additional Paid in Capital | $40,351 | $60,191 | $59,318 |
| Retained Earnings (Accumulated Deficit) | $-40,856 | $-51,281 | $-55,794 |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | — | $-2 | $-10 |
| Stockholders' Equity Attributable to Parent | $-503 | $8,910 | $3,517 |
| Preferred Stock, Shares Authorized | — | 150,000,000 | 5,000,000 |
| Preferred Stock, Shares Issued | — | 5,166 | 3,911 |
| (in thousands, except per share data) | FY 2024 | FY 2025 | TTM |
|---|---|---|---|
| Net Income (Loss) Attributable to Parent | $-6,535 | $-8,462 | $-8,403 |
| Depreciation, Depletion and Amortization | $72 | $89 | $113 |
| Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax | — | $-2 | $-2 |
| Share-based Payment Arrangement, Noncash Expense | $2,035 | $2,329 | $1,937 |
| Increase (Decrease) in Accounts Receivable | $-155 | $678 | $518 |
| Increase (Decrease) in Other Current Assets | $-151 | $195 | $181 |
| Increase (Decrease) in Accounts Payable | $601 | $-98 | $82 |
| Increase (Decrease) in Accrued Liabilities | $-48 | $8 | $97 |
| Increase (Decrease) in Deferred Revenue | $292 | $101 | $20 |
| Increase (Decrease) in Deposit Assets | — | $9 | $9 |
| Increase (Decrease) in Other Current Liabilities | $0 | $1 | $-65 |
| Net Cash Provided by (Used in) Operating Activities | $-3,277 | $-6,917 | $-7,070 |
| Payments to Acquire Property, Plant, and Equipment | $27 | $315 | $214 |
| Net Cash Provided by (Used in) Investing Activities | $-27 | $-315 | $-214 |
| Proceeds from Issuance of Common Stock | — | $128 | $143 |
| Proceeds from Issuance of Preferred Stock and Preference Stock | — | $17,250 | $3,500 |
| Proceeds from (Payments for) Other Financing Activities | — | $512 | $512 |
| Payments of Stock Issuance Costs | — | $2,257 | $504 |
| Net Cash Provided by (Used in) Financing Activities | $-685 | $15,633 | $3,366 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $-3,989 | $8,401 | $-3,926 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $52 | $8,453 | $7,306 |